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Abstract: A novel botanical dietary supplement, formulated as a chewable tablet containing a
defined mixture of Souroubea spp. vine and Platanus spp. Bark, was tested as a canine anxiolytic
for thunderstorm noise-induced stress (noise aversion). The tablet contained five highly stable
triterpenes and delivered 10 mg of the active ingredient betulinic acid (BA) for an intended 1 mg/kg
dose in a 10 kg dog. BA in tablets was stable for 30 months in storage at 23 ◦ C. Efficacy of the tablets
in reducing anxiety in dogs was assessed in a blinded, placebo-controlled study by recording changes
in blood cortisol levels and measures of behavioral activity in response to recorded intermittent
thunder. Sixty beagles were assigned into groups receiving: placebo, 0.5×, 1×, 2×, and 4× dose, or
the positive control (diazepam), for five days. Reduction in anxiety measures was partially dosedependent and the 1× dose was effective in reducing inactivity time (p = 0.0111) or increased activity
time (p = 0.0299) compared with placebo, indicating a decrease in anxiety response. Cortisol measures
also showed a dose-dependent reduction in cortisol in dogs treated with the test tablet.

Adela Pintea and Wolfgang Sippl

Keywords: triterpenes; anxiety; Souroubea; Platanus; dietary supplement; noise aversion; canines
Received: 4 March 2021
Accepted: 29 March 2021
Published: 3 April 2021

1. Introduction
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affiliations.

Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).

In our research program on botanicals with anxiety-reducing properties, we discovered that extracts of neotropical vines, Souroubea sympetala V.A. Richt and Souroubea gilgii
Gilg. (Marcgraviaceae), had potent anxiety-reducing properties in several rat models of
anxiety, including elevated plus-maze, fear-potentiated startle and social interaction [1].
Through bioassay-guided fractionation [2], the active fraction was found to contain five
triterpenes (Figure 1). Betulinic acid was found to be the most active component, but a
combination of betulinic acid and amyrins was significantly more effective in reducing
behaviors associated with anxiety than betulinic acid alone. Other phytochemicals found
in whole extracts included hydroxyursolic acid, taraxenyl trans-4-hydroxy-cinnamate, and
2-α-hydroxyursolic acid, isolated as its methyl ester, 2-α-hydroxymaslinic acid [2]. Further
investigation showed that the treatment was able to reduce levels of the stress-induced hormones cortisol and corticosterone to normal levels in restrained rodents, fish, and suckling
pigs [3,4]. Using antagonists in vivo, the plant extracts and active principles were shown
to act, at least in part, at the GABAA -benzodiazepine receptor. However, unlike valium,
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number of anxiety conditions occur in dogs, we chose to target a major
problem for owners—noise aversion. Thunderstorms, fireworks, and other loud noises
can cause great stress and anxiety in otherwise normal animals. This temporary condition
is a suitable application for an effective dietary supplement treatment. In a survey of
dog owners, Reiner [10] reported that they had some success with behavioral techniques,
but the existing dietary supplements available at the time provided relatively low levels
(27–35%) of effective treatments.
Due to the significant anxiolytic effects of Souroubea Platanus seen in other animals,
we tested its effectiveness in a well-established thunderstorm model [11,12] with a group
of beagle dogs, representative of companion dogs of mixed ages and temperaments. Dogs
were monitored for 9 min in a specially constructed room for behavioral measures before
(3 min), during (3 min), and after (3 min) a recording of thunderstorm sounds was played.
Serum cortisol levels were measured as a stress biomarker prior to entering the room and
immediately following test completion. Activity measures (distance travelled, activity, and
inactivity) were collected and analyzed using Ethnovision XT (Noldus, Wageningen, The
Netherlands) system activity software.
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11.92
(0.472)
0.376
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or 0.5×, 1×, 2×, or 4× doses of Souroubea-Platanus canine tablets, dogs receiving the
positive control diazepam had significantly lower inactivity time scores (for behaviors such
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as freezing) than placebo-treated dogs did, as expected, indicating lower anxiety than in the
placebo group (Table 2). For dogs in the groups receiving 0×, 0.5×, 1×, and 2× doses, the
mean (standard error) change in inactivity score was dose-dependent by linear regression
analysis (change in activity = 23.8 (±2.7) × dose, n = 4, r2 = 0.79). In addition, dogs
receiving Souroubea-Platanus tablets at doses of 1× and 2× had significantly less inactivity
time compared with dogs receiving placebo (p = 0.0111 and p = 0.0084, respectively). Dogs
in the 4× group did not follow this trend, exhibiting greater total inactivity than dogs
receiving 1× or 2× activity, although trending below the placebo level.
Table 2. Least square means (LSMean) of activity and inactivity time in seconds by dose, and paired difference tests of time
for a specific dose versus placebo.
Dose

Inactivity LSMean

Change in Inactivity

p-Value

Activity LSMean

Change in Activity

p-Value

Placebo
0.5× *
1×
2×
4×
Diazepam

114.48
106.48
72.61
70.14
90.41
61.31

8.01
41.87
44.34
24.08
53.17

0.6162
0.0111 a
0.0084 a
0.1358
0.0016 a

24.46
24.21
44.60
39.92
45.93
58.99

0.244
−20.14
−15.47
−21.48
−34.53

0.9783
0.0299 a
0.0942 b
0.0199 a
0.0003 a

* relative to recommended 1× dose of tablet. a Statistically significant.

b

Marginal significance.

A second measure of anxiety, the activity score, focused on normal behaviors. As expected,
in the diazepam-treated group the activity score was significantly higher than that of the
placebo-treated group. Although there was no clear dose-response relationship, dogs receiving
1× and 4× doses had significantly greater activity time compared with dogs receiving placebo
(p = 0.0299 and p = 0.0199, respectively) and marginal significance was seen in dogs receiving
2× dose (p = 0.0942). At the lowest dose (0.5×), there was no significant change.
2.3. Cortisol Results
Groups of beagles were identified as cortisol responders when the serum cortisol
was elevated by >13% following exposure to thunder sounds, compared with pretest
baseline levels (i.e., before any drugs were administered (Figure 3a)). After the drug
was administered in these dogs, the mean prethunder cortisol levels were not different
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3. Discussion
The results showed that the main anxiolytic triterpenoid compounds, betulinic acid
and α-amyrin, were stable in the tablet for 30 months—an important consideration in an
efficacy trial and for future practical applications. Stability in botanicals is a concern, as in
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3. Discussion
The results showed that the main anxiolytic triterpenoid compounds, betulinic acid
and α-amyrin, were stable in the tablet for 30 months—an important consideration in an
efficacy trial and for future practical applications. Stability in botanicals is a concern, as in
our experience some active principles, such as alkamides in echinacea, decline significantly
in concentration in a period of 6–12 months.
The results showed that orally administered Souroubea-Platanus tablets reduced both
behavioral and biochemical outcome measures which assessed the effect of the sound of
thunder on anxiety and stress in dogs. This study compared the effectiveness of SouroubeaPlatanus tablets at four dose levels with that of diazepam and a placebo control. The
botanical treatment was significantly effective in all measures at the intended 1× dose,
reducing inactivity and increasing activity measures in all dogs and cortisol in the responding dogs, compared with placebo-treated dogs. The botanical treatment showed a
significant dose–response effect on inactivity measures and an obvious dose-dependent
trend in cortisol results in responding dogs.
Cortisol is an objective biochemical measure of the stress response and does not require
observer assessments. There was a clear dose–response effect in lowering post-thunder
cortisol compared with the elevated levels seen in the control. The botanical treatments
were somewhat less effective than the diazepam treatment for cortisol lowering, but this is
to be expected with a botanical dietary supplement and may be desirable for treatment
of otherwise healthy dogs, as the treatment did not cause the well-known, undesirable
effects of valium (withdrawal symptoms and motility impairment) in 28 day treatments
of rodents.
Collectively, these findings provide support for the use of Souroubea-Platanus tablets
in reducing noise-induced anxiety in dogs, by demonstrating their effectiveness in reduced
cortisol release, increased activity measures in response to thunder and reduced inactivity
measures. In terms of future work, Souroubea-Platanus tablets may have effectiveness in
reducing conditioned anxiety in dogs, as has been demonstrated in rat models [13]. Further
studies on botanicals with higher amyrin content may improve potency.
Overall, this study suggests that Souroubea spp. and Platanus spp. exert anxiolytic
effects in dogs by inhibiting cortisol release and helping to maintain normal behavior. The
results also suggest that the lowest effective dose in dogs is the currently recommended
dosage (i.e., 1× dose). The results support their use as an effective and natural anxiolytic
for dogs during periods of exposure to loud noises, such as thunder.
Until recently, the development of evidence-based botanicals for the animal healthcare
market has lagged behind the human healthcare market. With this study on Souroubea
Platanus and recent publications, such as Mastinu et al. [14] showing the protective effect
of Gynostemma pentaphyllum against lipopolysaccharide-induced inflammation and motor
alteration, the botanical options for animal healthcare are increasing.
4. Materials and Methods
4.1. Drugs
Diazepam (Valium, Lot No. S12C02) was used as a positive control article and was
administered at a dose of 0.5 mg/kg.
4.2. Tablet Preparation and Analysis
The growth and collection of plant materials and their formulation into a 3.5 g chewable tablet has been described in detail elsewhere [12]. The Souroubea sympetala was identified by taxonomist P. Sanchez (Voucher# OTT19994) and plant material was sustainably
harvested from agricultural production of three-year-old vines in Costa Rica. Wild collection of Platanus occidentalis (voucher #19608) shedding bark was undertaken in Niagara and
Essex counties, Ontario, without injury to trees [9]. The tablets were formulated in Guelph,
Ontario, with 55:45 w:w dry powdered Souroubea sympetala vine: Platanus occidentalis bark, a
beef flavoring, and a binding agent. Each 3.5 g tablet was formulated to contain a minimum
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of 10 mg betulinic acid. The product was analyzed with a validated HPLC-MS method
for triterpene content [6]. For the efficacy trial, the mean (SE) triterpenoid concentration
was reported previously [8] as 3.22 (0.21) mg/g betulinic acid, 20 (0.01) mg/g ursolic acid,
0.24 (0.02) mg/g lupeol, 12 (0.01) mg/g β-amyrin, and 16 (0.00) mg/g α-amyrin (n = 3).
In the placebo, the plant material was replaced with microcrystalline cellulose, as described in the safety trial [8]. Tablets prepared from the same lot were used in the stability
trial (Table 1).
4.3. Experimental Study Design
4.3.1. Animal Welfare
The animal efficacy study was placebo-controlled, randomized, and double-blinded.
Procedures were designed to avoid or minimize discomfort, distress, and pain to the
animals in accordance with the principles and the guidelines of the Canadian Council on
Animal Care (CCAC). To ensure compliance, the experimental protocol (VRI30-12008-CE)
was reviewed and approved by the test facility’s Animal Care Committee before the start
of the trial.
4.3.2. Blinding
The principal study investigator was blinded to experimental groups for the duration
of the study. Study coordinators and laboratory personnel involved in testing and data
recording were also blinded for experimental groups during the study. Lab technicians
dosing the animals were the only study personnel familiar with the experimental groups,
however they did not participate in data collection and analysis.
4.3.3. Study Animals and Experimental Groups
The animal study was conducted at the Contract Research Organization located in
Fergus, Ontario, Canada. For study purposes, the animals used in the study were laboratory,
purposely bred beagle dogs. Sixty (60) beagle dogs, ranging in age from 1.4 years to 17 years
and in weight from 6.1 kg to 17.8 kg, were included in the study. All dogs enrolled into
the study were in good physical health, with no clinically significant health abnormalities
based on prestudy examinations (physical examinations, hematology, clinical chemistry,
and urinalysis). Dogs were stratified based on cortisol response to thunderstorm sounds
at baseline as the primary measure, and global anxiety as the secondary measure. Dogs
were considered cortisol responders if they showed 13% or greater response at the end
of the session than before the thunderstorm session. Animals with elevated cortisol
levels were equally randomized into experimental groups. Animals were randomized to
one of six experimental groups, with ten dogs per group: (1) negative control (placebo);
(2) positive control (diazepam); (3) 0.5×; (4) 1×, (5) 2×, or (6) 4× the recommended dose
of test product.
4.3.4. Testing Procedure
Testing procedures were performed in a room designed specifically to suit a model
of noise-induced anxiety with recorded thunderstorm sounds, and to collect measures of
anxiety and fear-related behaviors, such as activity or inactivity duration and frequency,
and time spent in a hide box, as previously described [11]. The thunderstorm test consisted
of an open field-testing room and an audio-recording of thunderstorm sounds [11]. Each
testing session lasted nine minutes, where the first three minutes provided baseline data,
whereas during minutes 4–6 the dogs were subjected to a taped presentation of thunder.
No audible stimulus was provided during the final three minutes, which served as the
post-thunder interval [11]. The entire study was designed in a manner such that each
animal entered the test room on five occasions: once during the adaptation phase (no audio
stimuli during 4–6 min); once during the thunder-test baseline phase (audio stimuli during
4–6 min); once during the open-field baseline phase (no audio stimuli during 4–6 min);
once during the thunder-test treatment phase (audio stimuli during 4–6 min); and once
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during the open-field treatment phase (no audio stimuli during 4–6 min) (Table 1). The
study procedures were carried out in cohorts for each phase following parallel-matched
design so that each animal in each experimental group was tested with the same number
of days between tests. Following thunderstorm and open-field baseline tests, dogs were
dosed for five consecutive days with either placebo, diazepam, or a specific dose of the test
product. After five days of dosing, all dogs were subjected to another thunderstorm test
(thunder-treatment phase), followed by the open-field treatment phase, after which the
anxiolytic properties of the tested products were determined.
4.3.5. Assessment of Efficacy
A total of two different data categories were assessed to determine the anxiolytic
properties of the test product. The first category was focused on the effect of thunder on
changes in behavioral activity [11], while the second utilized serum cortisol as a physiological measure. Blood samples for cortisol analysis were taken for the two thunder
tests (in the baseline and treatment phases). The other measures were taken for all four
sessions (two thunderstorm and two open-field sessions; no data was collected during the
adaptation phase). Blood was obtained for serum cortisol testing by venipuncture from
the jugular vein at 60 min prior to the presentation of thunder and at 10 and 60 min postthunder. Objective behavioral activity was measured by using the Ethnovision XT (Noldus,
Wageningen, Netherlands) system. The following parameters served as the dependent
variables for the activity analyses: activity time (total movement within the test room);
inactivity time (time spent inactive); and inactivity frequency (frequency of switching from
active to inactive and back).
4.3.6. Statistical Analysis
Cortisol results were analyzed using repeated measures ANOVA at baseline to validate
the model. Subsequently, repeated measures ANOVA that included both baseline and
treatment data were carried out. For the cortisol levels and activity and observational
anxiety measures, a baseline analysis was carried out to validate the model by establishing
a physiological and behavioral change in response to the presentation of thunder and
following the thunder interval. The data were analyzed with repeated measures ANOVA
with time-interval (prethunder, thunder and post-thunder) as within-subject variables
and group as between-subject variables. Tukey’s multiple comparisons were used, as
appropriate, to compare different groups of data with each other. Dunnett’s test was used,
as appropriate, to compare the individual groups with the control group. Baseline analysis
of conditioned anxiety was assessed by comparing performance during the first three
minutes of the prethunder test with performance of the first three minutes of the open-field
test using a repeated measures ANOVA.
Treatment effects were first assessed by comparing presentation of thunder during
the initial thunderstorm test. Furthermore, we compared the response during thunder to
the response during the control open-field test. The final analysis compared the response
during the baseline thunderstorm test with the response to the thunderstorm test under
treatment conditions.
Author Contributions: Growth and collection of the botanicals and formulation and analysis of the
tablets was undertaken by R.L., M.G., T.D., P.S.V., J.B. and J.A. Design of behavioral assays was
undertaken by A.M., Z.M., G.L. and B.M. Behavioral and cortisol measures were undertaken by G.L.,
B.M. and A.M. All authors have read and agreed to the published version of the manuscript.
Funding: Funding for this study was provided by Bioniche Life Sciences Inc. (Belleville, Ontario,
Canada), the Natural Sciences and Engineering Research Council of Canada (grant # RGPINé06072015), and Souroubea Botanicals Inc.
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